Abstract
Objective: This study aimed to assess the prevalence of migraine, determine the associated disabilities, and evaluate the impact of
migraine on the quality of life among students in private sector universities in Peshawar.
Study Design: A cross-sectional study was conducted.
Place and duration of study: A cross-sectional study was conducted from January to June 2023, involving 226 students 122 males
and 104 females, aged 19 to 24 years, attending private universities in Peshawar.
Material and Methods: A cross-sectional study was conducted from January to June 2023, involving 226 students 122 males and
104 females, aged 19 to 24 years, attending private universities in Peshawar.
Results: Among the male participants, 33.6% reported experiencing migraine, while 66.4% did not. In contrast, 38.5% female
participants experienced migraine, and 61.5% did not. According to the migraine disability assessment, 145 participants 64.5%
reported no disability, 2.7% had minimal or no disability, 9.7% had moderate disability, 19.9% had severe disability, and 3.5%
experienced extreme disability.
Conclusion: The prevalence of migraine was slightly higher among females than males. Significant risk factors associated with
migraine included head injury, poor neck posture, nerve tension from accidents, and cervicogenic pain.
References
1. Olesen J. Migraine classification committee of the international migraine society (IHS) the international classification of migraine disorders. Cephalalgia. 2018;38(1):1-211.
2. Andree C, Vaillant M, Barre J, Katsarava Z, Lainez JM, Lair M-L, et al. Development and validation of the EUROLIGHT questionnaire to evaluate the burden of primary migraine disorders in Europe. Cephalalgia. 2010;30(9):1082-100.
3. Sunada Y, Shimizu T, Nakase H, Ohta S, Asaoka T, Amano S, et al. Inherited amyloid polyneuropathy type IV (gelsolin variant) in a Japanese family. Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society. 1993;33(1):57-62.
4. Charles A. Migraine: a brain state. Current opinion in neurology. 2013;26(3):235-9.
5. Fischera M, Marziniak M, Gralow I, Evers S. The incidence and prevalence of cluster migraine: a meta-analysis of population-based studies. Cephalalgia. 2008;28(6):614-8.
6. Ran Y, Liu H, Zhang M, Dong Z, Yu S. Laugh‐Induced Migraine: Clinical Features and Literature Review. Migraine: The Journal of Head and Face Pain. 2017;57(10):1498-506.
7. Gaul C, van Doorn C, Webering N, Dlugaj M, Katsarava Z, Diener H-C, et al. Clinical outcome of a migraine-specific multidisciplinary treatment program and adherence to treatment recommendations in a tertiary migraine center: an observational study. The journal of migraine and pain. 2011;12(4):475-83.
8. Ashina H, Porreca F, Anderson T, Amin FM, Ashina M, Schytz HW, et al. Post-traumatic migraine: epidemiology and pathophysiological insights. Nature Reviews Neurology. 2019;15(10):607-17.
9. Coppola G, Di Lorenzo C, Serrao M, Parisi V, Schoenen J, Pierelli F. Pathophysiological targets for non-pharmacological treatment of migraine. Cephalalgia. 2016;36(12):1103-11.
10. May A, Leone M, Afra J, Linde M, Sándor P, Evers S, et al. EFNS guidelines on the treatment of cluster migraine and other trigeminal‐autonomic cephalalgias. European Journal of Neurology. 2006;13(10):1066-77.
11. Charles A. The pathophysiology of migraine: implications for clinical management. The Lancet Neurology. 2018;17(2):174-82.
12. Diener H-C, Charles A, Goadsby PJ, Holle D. New therapeutic approaches for the prevention and treatment of migraine. The Lancet Neurology. 2015;14(10):1010-22.
13. Blumenfeld A, Varon S, Wilcox T, Buse D, Kawata A, Manack A, et al. Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS). Cephalalgia. 2011;31(3):301-15.
14. Justo ACBDC, Fernandes D, Moura DMD, Da Silva LGD, De Almeida EO, Barbosa GAS. Acupuncture in temporomandibular disorder myofascial pain treatment: a systematic review. CEP. 2017;59056(000).
15. Shaik MM, Hassan NB, Tan HL, Bhaskar S, Gan SH. Validity and reliability of the Bahasa Melayu version of the migraine disability assessment questionnaire. BioMed research international. 2014;2014(1):435856.
16. Yeh WZ, Blizzard L, Taylor BV. What is the actual prevalence of migraine? Brain and behavior. 2018;8(6):e00950.
17. Terwindt G, Ferrari M, Tijhuis M, Groenen S, Picavet H, Launer L. The impact of migraine on quality of life in the general population: the GEM study. Neurology. 2000;55(5):624-9.
18. Khan A, Khattak H, Jamali R, Rashid H, Riaz A, Ibrahimzai AK. Prevalence of migraine, its common triggering factors and coping strategies in medical students of Peshawar. Khyber Med Univ J. 2012;4(4):187-92.Spelten E, Thomas B, O'Meara PF, Maguire BJ, FitzGerald D, Begg SJ. Organisational interventions for preventing and minimising aggression directed towards healthcare workers by patients and patient advocates. Cochrane Database of Systematic Reviews. 2020(4).
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Copyright (c) 2026 Journal of Nursing and Allied Health